NXTCL · NextCell Pharma AB · Insider Trading
Market Cap
113.40M SEK
Shares
111.39M
Transactions in NextCell Pharma AB securities by directors, senior managers and their closely associated persons, as published by the market regulator under the EU Market Abuse Regulation.
Director and related-person transactions
Source-reported director and related-person transactions, including amendments and historical rows. Not a complete insider-ownership register. Coverage is limited to captured publication days; gaps may exist between the first and last day. A verified issuer LEI includes other instruments of that issuer; an ISIN-only match covers that security. Instrument types and transaction descriptions are retained verbatim; do not sum revised, historical or derivative rows as share purchases. Publication timestamps are local source times.
| Transaction date | Person | Transaction | Instrument | Volume | Price | Status |
|---|---|---|---|---|---|---|
| 2025-06-16 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: Yes | Disposal | NextCell Pharma AB Share · SE0009723125 | 199891 Quantity | 0.9849 SEK | Current |
| 2025-06-16 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: Yes | Acquisition | NextCell Pharma AB Share · SE0009723125 | 198891 Quantity | 0.9939 SEK | Current |
| 2025-06-13 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: Yes | Disposal | NextCell Pharma AB Share · SE0009723125 | 217389 Quantity | 0.9916 SEK | Current |
| 2025-06-13 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: Yes | Acquisition | NextCell Pharma AB Share · SE0009723125 | 218389 Quantity | 1.0165 SEK | Current |
| 2025-05-30 | Mathias Svahn Chief Executive Officer (CEO)/Managing Directory · Related person: | Exercise increase | NextCell Pharma AB Share · SE0009723125 | 454019 Quantity | 1 SEK | Current Fel transaktionskaraktär angiven |
| 2025-05-30 | Mathias Svahn Chief Executive Officer (CEO)/Managing Directory · Related person: Yes | Exercise increase | NextCell Pharma AB Share · SE0009723125 | 62894 Quantity | 1 SEK | Current Fel transaktionskaraktär angiven |
| 2025-05-30 | Mathias Svahn Chief Executive Officer (CEO)/Managing Directory · Related person: Yes | Exercise decrease | NextCell Pharma AB TO2 Option · | 62894 Quantity | 0 SEK | Current |
| 2025-05-30 | Mathias Svahn Chief Executive Officer (CEO)/Managing Directory · Related person: | Exercise decrease | NextCell Pharma AB TO2 Option · | 454019 Quantity | 0 SEK | Current |
| 2025-05-30 | Mathias Svahn Chief Executive Officer (CEO)/Managing Directory · Related person: Yes | Subscription | NextCell Pharma AB Share · SE0009723125 | 62894 Quantity | 1 SEK | Revised |
| 2025-05-30 | Mathias Svahn Chief Executive Officer (CEO)/Managing Directory · Related person: | Subscription | NextCell Pharma AB Share · SE0009723125 | 454019 Quantity | 1 SEK | Revised |
| 2025-05-30 | Hans-Peter Ekre Chairman of the Board of Directors · Related person: Yes | Exercise increase | NextCell Pharma Share · SE0009723125 | 132144 Quantity | 1 SEK | Current |
| 2025-05-30 | Hans-Peter Ekre Chairman of the Board of Directors · Related person: Yes | Exercise decrease | NextCell Pharma AB TO2 Subcription warrant · | 132144 Quantity | 0 SEK | Current |
| 2025-05-30 | NextCell Pharma AB Chairman of the Board of Directors · Related person: | Exercise decrease | NextCell Pharma AB TO2 Subcription warrant · | 53000 Quantity | 0 SEK | Current |
| 2025-05-30 | NextCell Pharma AB Chairman of the Board of Directors · Related person: | Exercise increase | NextCell Pharma AB Share · SE0009723125 | 53000 Quantity | 1 SEK | Current |
| 2025-05-31 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: Yes | Subscription | NextCell Pharma AB BTU BTU · SE0022240867 | 298440 Quantity | 1 SEK | Revised |
| 2025-05-30 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: Yes | Exercise decrease | NextCell Pharma AB TO2 Subcription warrant · SE0022240800 | 298440 Quantity | 0 SEK | Current Fel instrument rapporterade, kompletterat |
| 2025-05-30 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: Yes | Exercise increase | NextCell Pharma AB Share · SE0009723125 | 298440 Quantity | 1 SEK | Current Fel instrument rapporterade, kompletterat |
| 2025-05-30 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: | Exercise decrease | NextCell Pharma AB TO2 Subcription warrant · SE0022240800 | 1320 Quantity | 0 SEK | Current Fel instrument rapporterade, kompletterat |
| 2025-05-30 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: | Exercise increase | NextCell Pharma AB Share · SE0009723125 | 1320 Quantity | 1 SEK | Current Fel instrument rapporterade, kompletterat |
| 2025-05-30 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: | Subscription | NextCell Pharma AB BTU BTU · SE0022240867 | 1320 Quantity | 1 SEK | Revised |
| 2025-05-27 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: Yes | Acquisition | NextCell Pharma TO2 Subcription warrant · SE0022240800 | 20000 Quantity | 0.005 SEK | Current |
| 2025-05-09 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: Yes | Acquisition | NextCell Pharma AB TO2 Subcription warrant · SE0022240800 | 50000 Quantity | 0.08 SEK | Current |
| 2025-04-28 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: Yes | Acquisition | NextCell Pharma AB TO2 Subcription warrant · SE0022240800 | 100000 Quantity | 0.09 SEK | Current |
| 2024-12-18 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: Yes | Acquisition | NXTCL Share · SE0009723125 | 15000 Quantity | 2.36 SEK | Current |
| 2024-12-18 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: Yes | Acquisition | NXTCL TO 2 Subcription warrant · SE0022240800 | 40000 Quantity | 0.625 SEK | Current |
| 2024-06-19 | Mathias Svahn Chief Executive Officer (CEO)/Managing Directory · Related person: | Disposal | NextCell Pharma AB Share · SE0022240867 | 5000 Quantity | 1.5 SEK | Current |
| 2024-06-19 | Mathias Svahn Chief Executive Officer (CEO)/Managing Directory · Related person: | Acquisition | NextCell Pharma AB BTU BTU · SE0022240867 | 10000 Quantity | 1.54 SEK | Current |
| 2024-06-18 | Mathias Svahn Chief Executive Officer (CEO)/Managing Directory · Related person: | Disposal | NextCell Pharma AB Share · SE0022240867 | 11000 Quantity | 1.4211 SEK | Current |
| 2024-06-18 | Mathias Svahn Chief Executive Officer (CEO)/Managing Directory · Related person: | Acquisition | NextCell Pharma BTU BTU · SE0022240867 | 12526 Quantity | 1.419 SEK | Current |
| 2024-06-17 | Hans-Peter Ekre Chairman of the Board of Directors · Related person: Yes | Acquisition | NextCell Pharma AB BTU BTU · SE0022240867 | 109972 Quantity | 1.06 SEK | Current Lägre antal BTU i transaktion 2 |
| 2024-06-17 | Hans-Peter Ekre Chairman of the Board of Directors · Related person: Yes | Acquisition | NextCell Pharma AB BTU BTU · SE0022240867 | 1883 Quantity | 1.06 SEK | Current Lägre antal BTU i transaktion 2 |
| 2024-06-17 | Hans Peter Torsten Ekre Chairman of the Board of Directors · Related person: | Acquisition | NextCell Pharma AB BTU · SE0022240867 | 74100 Quantity | 1.06 SEK | Current |
| 2024-06-17 | Hans-Peter Ekre Chairman of the Board of Directors · Related person: Yes | Acquisition | NextCell Pharma AB BTU BTU · SE0022240867 | 109972 Quantity | 1.06 SEK | Revised Lägre antal BTU i transaktion 2 |
| 2024-06-17 | Hans-Peter Ekre Chairman of the Board of Directors · Related person: Yes | Acquisition | NextCell Pharma AB BTU BTU · SE0022240867 | 1883 Quantity | 1.06 SEK | Revised Lägre antal BTU i transaktion 2 |
| 2024-06-17 | Hans-Peter Ekre Chairman of the Board of Directors · Related person: Yes | Acquisition | NextCell Pharma AB BTU BTU · SE0022240867 | 109972 Quantity | 1.06 SEK | Revised |
| 2024-06-17 | Hans-Peter Ekre Chairman of the Board of Directors · Related person: Yes | Acquisition | NextCell Pharma AB BTU BTU · SE0022240867 | 74100 Quantity | 1.06 SEK | Revised |
| 2024-06-17 | Mathias Svahn Chief Executive Officer (CEO)/Managing Directory · Related person: Yes | Subscription | NextCell Pharma AB BTU BTU · SE0022240867 | 427894 Quantity | 1.06 SEK | Current |
| 2024-06-17 | Mathias Svahn Chief Executive Officer (CEO)/Managing Directory · Related person: | Subscription | NextCell Pharma AB BTU BTU · | 131495 Quantity | 1.06 SEK | Current |
| 2024-06-14 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: Yes | Acquisition | NextCell Pharma AB BTU BTU · SE0022240867 | 71500 Quantity | 1.06 SEK | Current |
| 2024-06-14 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: Yes | Subscription | NextCell Pharma AB BTU BTU · SE0022240867 | 16940 Quantity | 1.06 SEK | Current |
| 2024-06-14 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: | Subscription | NextCell Pharma AB BTU BTU · SE0022240867 | 1320 Quantity | 1.06 SEK | Current |
| 2024-06-14 | Edvard Smith Member of the Board of Directors · Related person: | Subscription | NextCell Pharma AB. BTU BTU · SE0022240867 | 183253 Quantity | 1.06 SEK | Current |
| 2024-06-11 | Hans Peter Torsten Ekre Chairman of the Board of Directors · Related person: | Acquisition | NextCell Pharma UR 240529 Subscription right/Unit right · SE0009723125 | 301055 Quantity | 0.02 SEK | Current |
| 2024-06-11 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: Yes | Acquisition | NextCell UR Subscription right/Unit right · SE0022240859 | 715000 Quantity | 0.027684 SEK | Current Emitentten korrigerad och rättad |
| 2024-06-05 | Mathias Svahn Chief Executive Officer (CEO)/Managing Directory · Related person: | Acquisition | NextCell TR Subscription right/Unit right · SE0015243407 | 500000 Quantity | 0.0135 SEK | Current |
| 2024-06-05 | Mathias Svahn Chief Executive Officer (CEO)/Managing Directory · Related person: | Disposal | NextCell TR Subscription right/Unit right · SE0015243407 | 500000 Quantity | 0.018 SEK | Current |
| 2024-04-25 | Anders Essen-Möller Chairman of the Board of Directors · Related person: | Disposal | NextCell Pharma AB Share · SE0009723125 | 260000 Quantity | 1.26 SEK | Current |
| 2024-04-25 | Anders Essen-Möller Chairman of the Board of Directors · Related person: | Disposal | Diamyd Medical AB ser. B Share · SE0005162880 | 60000 Quantity | 10.85 SEK | Current |
| 2023-12-05 | Hans Peter Torsten Ekre Member of the Board of Directors · Related person: | Acquisition | NextCell Pharma AB Share · SE0009723125 | 32001 Quantity | 2.95 SEK | Current |
| 2023-08-24 | Patrik Fagerholm Chief Financial Officer (CFO) · Related person: Yes | Acquisition | NextCell Pharma AB Share · SE0009723125 | 7900 Quantity | 3.9 SEK | Current |
3746 publication days captured; dates between 2016-07-03 and 2026-10-06 may contain gaps. Checked 2026-10-07 11:08 UTC.
Showing 1–50 of 138 transactions